NCT04403334View on ClinicalTrials.gov

Postoperative Safety Outcomes of Intraoperative Intracameral Preservative-Free Moxifloxacin Versus Levofloxacin

PHASE4CompletedINTERVENTIONAL
Enrollment

114

Participants

Timeline

Start Date

January 2, 2018

Primary Completion Date

April 28, 2018

Study Completion Date

April 28, 2018

Conditions
Cataract SenileEndophthalmitisAntibiotic Side EffectSafety Issues
Interventions
DRUG

Levofloxacin Ophthalmic

0.1 ml of unpreserved 0.5% levofloxacin

DRUG

Moxifloxacin Ophthalmic

0.1 ml of unpreserved 0.5% moxifloxacin

Trial Locations (1)

1209

Peregrine Eye and Laser Instittute, Makati City

All Listed Sponsors
lead

Peregrine Eye and Laser Institute

OTHER

NCT04403334 - Postoperative Safety Outcomes of Intraoperative Intracameral Preservative-Free Moxifloxacin Versus Levofloxacin | Biotech Hunter | Biotech Hunter